Skip to main content

Table 1 Characteristics of recruited patients with and without adenomyosis

From: Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis

Variable name Control (n = 24) Adenomyosis (n = 30) p-value
Age
Mean (±S.D.) 41.3 ± 4.1 40.0 ± 2.2 0.13
Median (range) 42 (31—47) 40 (34—43)  
Parity
0 0 (0.0%) 4 (13.3%) 0.23
1 14 (58.3%) 16 (53.3%)  
  ≥ 2 10 (41.7%) 10 (33.3%)  
Menstrual phase
Proliferative 14 (58.3%) 16 (53.3%) 0.79
Secretory 10 (41.7%) 14 (46.7%)  
Amount of menses
Light 0 (0.0%) 1 (3.3%) 1.4 × 10−5
Moderate 24 (100.0%) 14 (46.7%)  
Heavy 0 (0.0%) 15 (50.0%)  
Severity of dysmenorrhea
None 22 (91.6%) 3 (10.0%) 4.8 × 10−10
Mild 1 (4.2%) 3 (10.0%)  
Moderate 1 (4.2%) 6 (20.0%)  
Severe 0 (0.0%) 18 (60.0%)  
Ovarian endometrioma
Absent 24 (100.0%) 28 (93.3%) 0.50
Present 0 (0.0%) 2 (6.7%)  
Deep endometriosis
Absent 24 (100.0%) 25 (83.3%) 0.059
Present 0 (0.0%) 5 (16.7%)  
Uterine fibroids
Absent 24 (100.0%) 21 (70.0%) 0.0029
Present 0 (0.0%) 9 (30.0%)  
Uterine size (in cm3)
Mean (±S.D.) 63.3 ± 21.0 304.8 ± 103.8 1.4 × 10−15
Median (range) 63.3 (33.0—116.8) 295.9 (130.3—531.1)